Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore) Meeting Abstract


Authors: Sartor, O.; Castellano Gauna, D. E.; Herrmann, K.; de Bono, J. S.; Shore, N. D.; Chi, K. N. N.; Crosby, M.; Piulats Rodriguez, J. M.; Flechon, A.; Wei, X. X.; Mahammedi, H.; Roubaud, G.; Ova, H.; Ghebremariam, S.; Kpamegan, E.; Kreisl, T. N.; Delgoshaie, N.; Lehnhoff, K.; Morris, M. J.; Fizazi, K.
Abstract Title: Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S1324
End Page: S1325
Language: English
ACCESSION: WOS:001087480203571
DOI: 10.1016/j.annonc.2023.10.085
PROVIDER: wos
Notes: Meeting Abstract: LBA13 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris